Global Breast Reconstruction Market Opportunity Analysis and Industry Forecast till 2031: By Product (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals,
Description
Global Breast Reconstruction Market Opportunity Analysis and Industry Forecast till 2031: By Product (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinic and Surgical Centers), and Region
The global breast reconstruction market size was USD 577 million in 2021 and it is anticipated to reach USD 748.1 million in 2031, growing at a CAGR of 2.6% from 2022-2031.
Breast reconstruction is an important facet of breast cancer management. It has a less cosmetic result. Breast reconstruction provides social, psychological, emotional and functional improvements, counting improved self-esteem, psychological health and body image.
Report Coverage
Market Trends and Drivers
The major factor boosting the growth of the market is an increasing awareness about breast reconstruction treatment. A number of patients choose breast reconstruction surgery after mastectomy. This can be primarily attributed to the growing concerns and increasing awareness of the safety and efficacy of reconstructive surgeries. This trend can be observed in both developed and emerging countries which are experiencing improvements in the standard of living.
The growth in awareness can be credited to initiatives taken by market players and stakeholders as well as independent bodies like the American Society of Plastic Surgeons (ASPS). ASPS, along with the Plastic Surgery Foundation, organized the Breast Reconstruction Awareness campaign to engage and educate women on reconstruction post breast cancer diagnosis. The primary target of the campaign was to educate women, family members, and the media that the breast cancer loop remains open until a woman is informed of her breast reconstruction options. Other primary events include the Association of Breast Surgery Conference 2020 in England and the 36th Annual Breast Surgery Symposium held in Georgia, US. In 2011, Canada launched the first BRA Day (Breast Reconstruction Awareness Day). This year, the American Society of Plastic Surgeons and The Plastic Surgery Foundation has joined forces with the Canadians to initiate BRA Day USA. On February 17, 2022, Tata Memorial Center organized a conference - Reconstruction and Cancer Care: Enhancing Quality Living with and Beyond Cancer to create awareness regarding breast reconstruction.
Market Restraints & Challenges
The major factor hindering the growth of the market is alternative non-surgical methods. After mastectomy, some women prefer breast reconstruction surgery. Others do not choose it due to a lack of awareness or other health issues such as obesity, skinniness, or change in blood flow dynamics. These women can choose alternatives to breast reconstruction, like custom breast prosthetics and going flat. Custom breast prosthetics can replicate the woman’s exact shape and create symmetry with the intact breast for single-mastectomy patients. These prosthetics are much cheaper than the breast reconstruction process and are available in the range of under USD 100 to USD 500 for high-quality products. The availability of alternatives, mainly non-surgical methods, is a key restraint to the breast reconstruction market.
Global Breast Reconstruction Market Segmentation
The report analyses the breast reconstruction market based on product, procedure, type, end user, and regions.
Global Breast Reconstruction Market by Product
On the basis of the product, it is segmented into breast implants, tissue expanders, and an acellular dermal matrix. The breast implants segment is likely to dominate the market during the forecast period. The growth of the segment is attributed to the increasing incidences of breast cancer and the rising number of breast reconstruction procedures.
Global Breast Reconstruction Market by Procedure
On the basis of procedure, it is segmented into immediate, delayed, and revision. The immediate segment is likely to dominate the market during the forecast period. The key factors boosting the growth of the market are the increasing number of breast reconstruction procedures combined with an increasing number of breast cancer patients.
Global Breast Reconstruction Market by Type
By type, it is segmented into unilateral, and bilateral. The unilateral segment is likely to dominate the market during the forecast period. The key factors propelling the growth of the market are rapid technological advancements coupled with the high growth opportunities in emerging markets and the rising development of 3D-printed implants.
Global Breast Reconstruction Market by End User
By end user, it is segmented into hospitals, cosmetology clinics and ambulatory surgical centers. The hospital segment is likely to dominate the market during the forecast period. The development and adoption of advanced technologies for breast reconstruction are likely to drive the breast reconstruction market during the projection period.
Geographical Analysis of Global Breast Reconstruction Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is anticipated to dominate in terms of breast reconstruction market share, due to rising awareness of breast cancer in the region. For instance, in November 2018, a breast reconstruction awareness program was conducted in the Windsor Regional Hospital, Canada, with the special purpose to help and educate local women regarding breast cancer and breast reconstruction.
Major Players of the Global Breast Reconstruction Market
The global breast reconstruction market report comprises players such as Mentor Worldwide LLC (Johnson & Johnson) (US), Allergan Aesthetics (an Abbvie company) (US), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (US), and Silimed (Brazil) among others.
COVID-19 Analysis
A number of countries across the world has seen elective surgeries being postponed owing to the pandemic. Since breast reconstruction surgery is elective, this has affected the prospects of the market. Reconstructive procedures utilize additional resources and increase the risk of complications; depending on the procedure, they also raise the chance of needing equipment, resources, or materials such as a hospital bed and PPE. This procedure also requires a number of office visits for tissue expander fill or other complications.
The US is one such country that has seen a decline in elective procedures due to cancellation or delay. Various governments in European and Asia Pacific countries have also taken judgments to postpone elective procedures until the COVID-19 situation stabilizes. For example, in March 2020, UK NHS hospitals were told to suspend all non-urgent elective surgeries for at least three months. Adding to that, the US Surgeon General, the CDC, and many medical specialties like the American College of Surgeons and the American Society of Anesthesiologists suggested the temporary cancellation of elective surgical procedures. Physician and facility willingness to resume elective surgery will differ by geographic location. Moreover, more than 1,500 breast cancer patients in the UK face long waits to have reconstructive surgery after hospitals could not operate on them during the COVID-19 pandemic.
Recent Developments
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
The global breast reconstruction market size was USD 577 million in 2021 and it is anticipated to reach USD 748.1 million in 2031, growing at a CAGR of 2.6% from 2022-2031.
Breast reconstruction is an important facet of breast cancer management. It has a less cosmetic result. Breast reconstruction provides social, psychological, emotional and functional improvements, counting improved self-esteem, psychological health and body image.
Report Coverage
Market Trends and Drivers
The major factor boosting the growth of the market is an increasing awareness about breast reconstruction treatment. A number of patients choose breast reconstruction surgery after mastectomy. This can be primarily attributed to the growing concerns and increasing awareness of the safety and efficacy of reconstructive surgeries. This trend can be observed in both developed and emerging countries which are experiencing improvements in the standard of living.
The growth in awareness can be credited to initiatives taken by market players and stakeholders as well as independent bodies like the American Society of Plastic Surgeons (ASPS). ASPS, along with the Plastic Surgery Foundation, organized the Breast Reconstruction Awareness campaign to engage and educate women on reconstruction post breast cancer diagnosis. The primary target of the campaign was to educate women, family members, and the media that the breast cancer loop remains open until a woman is informed of her breast reconstruction options. Other primary events include the Association of Breast Surgery Conference 2020 in England and the 36th Annual Breast Surgery Symposium held in Georgia, US. In 2011, Canada launched the first BRA Day (Breast Reconstruction Awareness Day). This year, the American Society of Plastic Surgeons and The Plastic Surgery Foundation has joined forces with the Canadians to initiate BRA Day USA. On February 17, 2022, Tata Memorial Center organized a conference - Reconstruction and Cancer Care: Enhancing Quality Living with and Beyond Cancer to create awareness regarding breast reconstruction.
Market Restraints & Challenges
The major factor hindering the growth of the market is alternative non-surgical methods. After mastectomy, some women prefer breast reconstruction surgery. Others do not choose it due to a lack of awareness or other health issues such as obesity, skinniness, or change in blood flow dynamics. These women can choose alternatives to breast reconstruction, like custom breast prosthetics and going flat. Custom breast prosthetics can replicate the woman’s exact shape and create symmetry with the intact breast for single-mastectomy patients. These prosthetics are much cheaper than the breast reconstruction process and are available in the range of under USD 100 to USD 500 for high-quality products. The availability of alternatives, mainly non-surgical methods, is a key restraint to the breast reconstruction market.
Global Breast Reconstruction Market Segmentation
The report analyses the breast reconstruction market based on product, procedure, type, end user, and regions.
On the basis of the product, it is segmented into breast implants, tissue expanders, and an acellular dermal matrix. The breast implants segment is likely to dominate the market during the forecast period. The growth of the segment is attributed to the increasing incidences of breast cancer and the rising number of breast reconstruction procedures.
Global Breast Reconstruction Market by Procedure
On the basis of procedure, it is segmented into immediate, delayed, and revision. The immediate segment is likely to dominate the market during the forecast period. The key factors boosting the growth of the market are the increasing number of breast reconstruction procedures combined with an increasing number of breast cancer patients.
Global Breast Reconstruction Market by Type
By type, it is segmented into unilateral, and bilateral. The unilateral segment is likely to dominate the market during the forecast period. The key factors propelling the growth of the market are rapid technological advancements coupled with the high growth opportunities in emerging markets and the rising development of 3D-printed implants.
Global Breast Reconstruction Market by End User
By end user, it is segmented into hospitals, cosmetology clinics and ambulatory surgical centers. The hospital segment is likely to dominate the market during the forecast period. The development and adoption of advanced technologies for breast reconstruction are likely to drive the breast reconstruction market during the projection period.
Geographical Analysis of Global Breast Reconstruction Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is anticipated to dominate in terms of breast reconstruction market share, due to rising awareness of breast cancer in the region. For instance, in November 2018, a breast reconstruction awareness program was conducted in the Windsor Regional Hospital, Canada, with the special purpose to help and educate local women regarding breast cancer and breast reconstruction.
Major Players of the Global Breast Reconstruction Market
The global breast reconstruction market report comprises players such as Mentor Worldwide LLC (Johnson & Johnson) (US), Allergan Aesthetics (an Abbvie company) (US), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (US), and Silimed (Brazil) among others.
COVID-19 Analysis
A number of countries across the world has seen elective surgeries being postponed owing to the pandemic. Since breast reconstruction surgery is elective, this has affected the prospects of the market. Reconstructive procedures utilize additional resources and increase the risk of complications; depending on the procedure, they also raise the chance of needing equipment, resources, or materials such as a hospital bed and PPE. This procedure also requires a number of office visits for tissue expander fill or other complications.
The US is one such country that has seen a decline in elective procedures due to cancellation or delay. Various governments in European and Asia Pacific countries have also taken judgments to postpone elective procedures until the COVID-19 situation stabilizes. For example, in March 2020, UK NHS hospitals were told to suspend all non-urgent elective surgeries for at least three months. Adding to that, the US Surgeon General, the CDC, and many medical specialties like the American College of Surgeons and the American Society of Anesthesiologists suggested the temporary cancellation of elective surgical procedures. Physician and facility willingness to resume elective surgery will differ by geographic location. Moreover, more than 1,500 breast cancer patients in the UK face long waits to have reconstructive surgery after hospitals could not operate on them during the COVID-19 pandemic.
Recent Developments
- 2022: Mentor Worldwide LLC (J&J) received the US FDA approval for a new Mentor Memory Gel boost breast implant.
- 2021: POLYTECH Health & Aesthetic received US FDA approval for the company’s textured breast implants
- 2020: Sientra received US FDA pre-market approval for its OPUS-branded breast implant products
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
167 Pages
- Chapter 1. MARKET INTRODUCTION
- 1.1. OBJECTIVES OF THE STUDY
- 1.2. MARKET DEFINITION AND RESEARCH & SCOPE
- 1.3. RESEARCH METHODOLOGIES
- 1.4. MARKET ESTIMATION TECHNIQUES
- Chapter 2. EXECUTIVE SUMMARY
- 2.1. SUMMARY
- 2.2. KEY HIGHLIGHTS OF THE MARKET
- Chapter 3. BREAST RECONSTRUCTION MARKET OUTLOOK
- 3.1. BREAST RECONSTRUCTION MARKET SEGMENTATION
- 3.2. MARKET DYNAMICS
- 3.2.1. MARKET DRIVERS
- 3.2.1.1. DRIVER 1
- 3.2.1.2. DRIVER 2
- 3.2.1.3. DRIVER 3
- 3.2.2. MARKET RESTRAINTS
- 3.2.2.1. RESTRAINT 1
- 3.2.2.2. RESTRAINT 2
- 3.2.3. MARKET OPPORTUNITIES
- 3.2.3.1. OPPORTUNITY 1
- 3.2.3.2. OPPORTUNITY 2
- 3.3. PORTER’S FIVE FORCES ANALYSIS
- 3.3.1. THREAT OF NEW ENTRANTS
- 3.3.2. THREAT OF SUBSTITUTES
- 3.3.3. BARGAINING POWER OF BUYERS
- 3.3.4. BARGAINING POWER OF SUPPLIER
- 3.3.5. COMPETITIVE RIVALRY
- 3.4. PESTLE ANALYSIS
- 3.5. VALUE CHAIN ANALYSIS
- 3.5.1. RAW MATERIAL SUPPLIERS
- 3.5.2. MANUFACTURERS
- 3.5.3. WHOLESALERS AND/OR RETAILERS
- 3.6. IMPACT OF THE RUSSIA AND UKRAINE WAR ON THE GLOBAL BREAST RECONSTRUCTION MARKET
- Chapter 4. ECONOMIC IMPACT OF COVID-19
- 4.1. OVERALL IMPACT OF COVID-19
- 4.2. IMPACT OF COVID ON THE GLOBAL BREAST RECONSTRUCTION MARKET
- 4.3. ECONOMIC IMPACT ANALYSIS
- Chapter 5. BREAST RECONSTRUCTION MARKET BY PRODUCT
- 5.1. MARKET OVERVIEW
- 5.2. BREAST IMPLANTS
- 5.2.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- 5.2.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- 5.3. TISSUE EXPANDERS
- 5.3.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- 5.3.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- 5.4. ACELLULAR DERMAL MATRIX
- 5.4.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- 5.4.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- Chapter 6. BREAST RECONSTRUCTION MARKET BY PROCEDURE
- 6.1. MARKET OVERVIEW
- 6.2. IMMEDIATE
- 6.2.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- 6.2.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- 6.3. DELAYED
- 6.3.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- 6.3.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- 6.4. REVISION
- 6.4.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- 6.4.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- Chapter 7. BREAST RECONSTRUCTION MARKET BY TYPE
- 7.1. MARKET OVERVIEW
- 7.2. UNILATERAL
- 7.2.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- 7.2.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- 7.3. BILATERAL
- 7.3.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- 7.3.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- Chapter 8. BREAST RECONSTRUCTION MARKET BY END USER
- 8.1. MARKET OVERVIEW
- 8.2. HOSPITALS
- 8.2.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- 8.2.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- 8.3. COSMETOLOGY CLINICS AND SURGICAL CENTERS
- 8.3.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- 8.3.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- Chapter 9. BREAST RECONSTRUCTION MARKET, BY REGION
- 9.1. OVERVIEW
- 9.2. NORTH AMERICA
- 9.2.1. KEY MARKET TRENDS AND OPPORTUNITIES
- 9.2.2. NORTH AMERICA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.2.3. NORTH AMERICA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.2.4. NORTH AMERICA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
- 9.2.5. THE U.S.
- 9.2.5.1. THE U.S. BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.2.5.2. THE U.S. BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.2.6. CANADA
- 9.2.6.1. CANADA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.2.6.2. CANADA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.2.7. MEXICO
- 9.2.7.1. MEXICO BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.2.7.2. MEXICO BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE PRODUCT, 2021-2031, ($MILLION)
- 9.3. EUROPE
- 9.3.1. KEY MARKET TRENDS AND OPPORTUNITIES
- 9.3.2. EUROPE BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.3.3. EUROPE BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.3.4. EUROPE BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
- 9.3.5. GERMANY
- 9.3.5.1. GERMANY BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.3.5.2. GERMANY BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.3.6. FRANCE
- 9.3.6.1. FRANCE BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.3.6.2. FRANCE BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.3.7. U.K.
- 9.3.7.1. U.K. BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.3.7.2. U.K. BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.3.8. SPAIN
- 9.3.8.1. SPAIN BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.3.8.2. SPAIN BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.3.9. ITALY
- 9.3.9.1. ITALY BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.3.9.2. ITALY BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.3.10. RUSSIA
- 9.3.10.1. RUSSIA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.3.10.2. RUSSIA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.3.11. REST OF EUROPE
- 9.3.11.1. REST OF EUROPE BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.3.11.2. REST OF EUROPE BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.4. ASIA-PACIFIC
- 9.4.1. KEY MARKET TRENDS AND OPPORTUNITIES
- 9.4.2. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
- 9.4.3. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.4.4. ASIA-PACIFIC BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.4.5. CHINA
- 9.4.5.1. CHINA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.4.5.2. CHINA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.4.6. INDIA
- 9.4.6.1. INDIA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.4.6.2. INDIA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.4.7. JAPAN
- 9.4.7.1. JAPAN BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.4.7.2. JAPAN BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.4.8. SOUTH KOREA
- 9.4.8.1. SOUTH KOREA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.4.8.2. SOUTH KOREA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.4.9. REST OF APAC
- 9.4.9.1. REST OF APAC BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.4.9.2. REST OF APAC BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.5. REST OF THE WORLD
- 9.5.1. KEY MARKET TRENDS AND OPPORTUNITIES
- 9.5.2. REST OF THE WORLD BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.5.3. REST OF THE WORLD BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.5.4. REST OF THE WORLD BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
- 9.5.5. LATIN AMERICA
- 9.5.5.1. LATIN AMERICA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.5.5.2. LATIN AMERICA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.5.6. MIDDLE EAST
- 9.5.6.1. MIDDLE EAST BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.5.6.2. MIDDLE EAST BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- 9.5.7. AFRICA
- 9.5.7.1. AFRICA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PRODUCT, 2021-2031, ($MILLION)
- 9.5.7.2. AFRICA BREAST RECONSTRUCTION MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
- Chapter 10. COMPETITIVE LANDSCAPE
- 10.1. MARKET OVERVIEW
- 10.2. MARKET SHARE ANALYSIS/KEY PLAYER POSITIONING
- 10.3. DEVELOPMENTAL STRATEGY BENCHMARKING
- 10.3.1. NEW PROCEDURE DEVELOPMENT
- 10.3.2. PRODUCT LAUNCHES
- 10.3.3. BUSINESS EXPANSIONS
- 10.3.4. PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS
- 10.3.5. MERGERS AND ACQUISITIONS
- n11.1. Mentor Worldwide LLC (Johnson & Johnson) (US)
- 11.1.1. COMPANY SNAPSHOT
- 11.1.2. FINANCIAL PERFORMANCE
- 11.1.3. PRODUCT OFFERINGS
- 11.1.4. KEY STRATEGIC INITIATIVES
- 11.1.5. SWOT ANALYSIS
- 11.2. Allergan Aesthetics (an Abbvie company) (US)
- 11.2.1. COMPANY SNAPSHOT
- 11.2.2. FINANCIAL PERFORMANCE
- 11.2.3. PRODUCT OFFERINGS
- 11.2.4. KEY STRATEGIC INITIATIVES
- 11.2.5. SWOT ANALYSIS
- 11.3. Ideal Implant Incorporated (US)
- 11.3.1. COMPANY SNAPSHOT
- 11.3.2. FINANCIAL PERFORMANCE
- 11.3.3. PRODUCT OFFERINGS
- 11.3.4. KEY STRATEGIC INITIATIVES
- 11.3.5. SWOT ANALYSIS
- 11.4. Sebbin (France)
- 11.4.1. COMPANY SNAPSHOT
- 11.4.2. FINANCIAL PERFORMANCE
- 11.4.3. PRODUCT OFFERINGS
- 11.4.4. KEY STRATEGIC INITIATIVES
- 11.4.5. SWOT ANALYSIS
- 11.5. GC Aesthetics (Ireland)
- 11.5.1. COMPANY SNAPSHOT
- 11.5.2. FINANCIAL PERFORMANCE
- 11.5.3. PRODUCT OFFERINGS
- 11.5.4. KEY STRATEGIC INITIATIVES
- 11.5.5. SWOT ANALYSIS
- 11.6. POLYTECH Health & Aesthetics (Germany)
- 11.6.1. COMPANY SNAPSHOT
- 11.6.2. FINANCIAL PERFORMANCE
- 11.6.3. PRODUCT OFFERINGS
- 11.6.4. KEY STRATEGIC INITIATIVES
- 11.6.5. SWOT ANALYSIS
- 11.7. Sientra (US)
- 11.7.1. COMPANY SNAPSHOT
- 11.7.2. FINANCIAL PERFORMANCE
- 11.7.3. PRODUCT OFFERINGS
- 11.7.4. KEY STRATEGIC INITIATIVES
- 11.7.5. SWOT ANALYSIS
- 11.8. Integra Lifesciences (US)
- 11.8.1. COMPANY SNAPSHOT
- 11.8.2. FINANCIAL PERFORMANCE
- 11.8.3. PRODUCT OFFERINGS
- 11.8.4. KEY STRATEGIC INITIATIVES
- 11.8.5. SWOT ANALYSIS
- 11.9. RTI Surgical Holdings (US)
- 11.9.1. COMPANY SNAPSHOT
- 11.9.2. FINANCIAL PERFORMANCE
- 11.9.3. PRODUCT OFFERINGS
- 11.9.4. KEY STRATEGIC INITIATIVES
- 11.9.5. SWOT ANALYSIS
- 11.10. Establishment Labs S.A. (US)
- 11.10.1. COMPANY SNAPSHOT
- 11.10.2. FINANCIAL PERFORMANCE
- 11.10.3. PRODUCT OFFERINGS
- 11.10.4. KEY STRATEGIC INITIATIVES
- 11.10.5. SWOT ANALYSIS
- 11.11. Silimed (Brazil)
- 11.11.1. COMPANY SNAPSHOT
- 11.11.2. FINANCIAL PERFORMANCE
- 11.11.3. PRODUCT OFFERINGS
- 11.11.4. KEY STRATEGIC INITIATIVES
- 11.11.5. SWOT ANALYSIS
- *The list of company is subject to change during the final compilation of the report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
